Stocks and Investing
Stocks and Investing
Fri, October 20, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Daniel Grosslight Maintained (TDOC) at Hold with Decreased Target to $21 on, Oct 20th, 2023
Daniel Grosslight of Citigroup, Maintained "Teladoc Health, Inc." (TDOC) at Hold with Decreased Target from $29 to $21 on, Oct 20th, 2023.
Daniel has made no other calls on TDOC in the last 4 months.
There are 4 other peers that have a rating on TDOC. Out of the 4 peers that are also analyzing TDOC, 3 agree with Daniel's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jailendra Singh of "Truist Securities" Reiterated at Hold and Held Target at $28 on, Monday, September 25th, 2023
- Jeff Garro of "Stephens & Co." Reiterated at Hold and Held Target at $28 on, Wednesday, July 26th, 2023
- Jonathan Yong of "Credit Suisse" Reiterated at Hold and Held Target at $27 on, Wednesday, July 26th, 2023
This is the rating of the analyst that currently disagrees with Daniel
- Sean Dodge of "RBC Capital" Reiterated at Buy and Held Target at $35 on, Wednesday, July 26th, 2023
Contributing Sources